In Silico Prediction and In Vitro Assessment Service

MedPharm’s in silico models are based on 20 years of experience. Each model ranks the ability of compounds to penetrate tissue based on key physiochemical information. Combining in silico investigations with API characterization helps our clients to make informed decisions on compound selection early in the development pathway. Our in vitro assessments allow compounds to be selected based on activity and permeability in ex vivo human tissue.